Daiichi Sankyo Co Ltd (MEX:4568)
MXN 635.96 0 (0%) Market Cap: 1.07 Til Enterprise Value: 969.66 Bil PE Ratio: 33.70 PB Ratio: 5.15 GF Score: 68/100

Daiichi Sankyo Co Ltd at JPMorgan Healthcare Conference Transcript

Jan 09, 2023 / 04:15PM GMT
Seiji Wakao
JPMorgan Chase & Co, Research Division - VP

So good morning, everyone. Welcome to the JPMorgan Healthcare Conference. I'm Seiji Wakao, Japan pharma analyst at JPMorgan. It's my great pleasure to introduce Sunao Manabe, Representative Director, President and CEO of Daiichi Sankyo. And from Q&A session, Dr. Ken Takeshita, the Global Head of Research and Development, we join. With that, I'm going to hand it over to Manabe-san.

Sunao Manabe
Daiichi Sankyo Company, Limited - President, Group CEO & Representative Director

Okay. Thank you, Wakao-san. Hello colleagues. Thank you for your strong interest in Daiichi Sankyo. Also, I really appreciate the JPMorgan for providing this good opportunity. I'm very happy to back here since 2020. Because of COVID-19, I was not able to participate in this conference last year, also in 2021. Taking this opportunity, I'd like to share the current status of Daiichi Sankyo. Okay, let's go to Slide #3. And today, I will start with a very brief overview of Daiichi Sankyo, then I will present on ENHERTU, our

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot